2.4.0.8 Html 69 146 1 false 30 0 false 9 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.cbi-biotech.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.cbi-biotech.com/taxonomy/role/StatementOfFinancialPositionClassified CONDENSED BALANCE SHEETS false false R3.htm 104 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.cbi-biotech.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical CONDENSED BALANCE SHEETS (Parenthetical) false false R4.htm 105 - Statement - CONDENSED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://www.cbi-biotech.com/taxonomy/role/StatementOfIncomeAlternative CONDENSED STATEMENTS OF OPERATIONS (Unaudited) false false R5.htm 106 - Statement - CONDENSED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) Sheet http://www.cbi-biotech.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome CONDENSED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) false false R6.htm 107 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.cbi-biotech.com/taxonomy/role/StatementOfCashFlowsIndirect CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) false false R7.htm 108 - Disclosure - Corporate overview Sheet http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock Corporate overview false false R8.htm 109 - Disclosure - Liquidity and management's plans Sheet http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsLiquidityAndManagementPlanDisclosureTextBlock Liquidity and management's plans false false R9.htm 110 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Summary of Significant Accounting Policies false false R10.htm 111 - Disclosure - Notes Receivable Notes http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsLoansNotesTradeAndOtherReceivablesDisclosureTextBlock Notes Receivable false false R11.htm 112 - Disclosure - Notes Payable Notes http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Notes Payable false false R12.htm 113 - Disclosure - Stockholders' Equity Sheet http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Stockholders' Equity false false R13.htm 114 - Disclosure - Legal Proceedings Sheet http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsLegalMattersAndContingenciesTextBlock Legal Proceedings false false R14.htm 115 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.cbi-biotech.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) false false R15.htm 116 - Disclosure - Corporate Overview - Additional Information (Detail) Sheet http://www.cbi-biotech.com/taxonomy/role/DisclosureCorporateOverviewAdditionalInformation Corporate Overview - Additional Information (Detail) false false R16.htm 117 - Disclosure - Liquidity and Management's Plans - Additional Information (Detail) Sheet http://www.cbi-biotech.com/taxonomy/role/DisclosureLiquidityAndManagementsPlansAdditionalInformation Liquidity and Management's Plans - Additional Information (Detail) false false R17.htm 118 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.cbi-biotech.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation Summary of Significant Accounting Policies - Additional Information (Detail) false false R18.htm 119 - Disclosure - Notes Receivable - Additional Information (Detail) Notes http://www.cbi-biotech.com/taxonomy/role/DisclosureNotesReceivableAdditionalInformation Notes Receivable - Additional Information (Detail) false false R19.htm 120 - Disclosure - Notes Payable - Additional Information (Detail) Notes http://www.cbi-biotech.com/taxonomy/role/DisclosureNotesPayableAdditionalInformation Notes Payable - Additional Information (Detail) false false R20.htm 121 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.cbi-biotech.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation Stockholders' Equity - Additional Information (Detail) false false All Reports Book All Reports Element us-gaap_ResearchAndDevelopmentExpense had a mix of decimals attribute values: -5 0. Process Flow-Through: 103 - Statement - CONDENSED BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Jan. 04, 2013' Process Flow-Through: 104 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Process Flow-Through: 105 - Statement - CONDENSED STATEMENTS OF OPERATIONS (Unaudited) Process Flow-Through: 107 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) hppi-20140630.xml hppi-20140630.xsd hppi-20140630_cal.xml hppi-20140630_def.xml hppi-20140630_lab.xml hppi-20140630_pre.xml true true